Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Accurately Record and Reconcile Controlled Drug Administration

Peterborough, New Hampshire Survey Completed on 06-13-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to establish and maintain an adequate system for recording the receipt and disposition of controlled drugs, specifically Hydromorphone, for one resident. The resident expressed concern about receiving the wrong dose of pain medication. Review of the Medication Administration Records (MAR) and Individual Patient's Narcotic Records revealed multiple instances where the resident was administered an incorrect dose of Hydromorphone, including full 2 mg tablets instead of the prescribed 1 mg (0.5 tablet) dose. These errors were confirmed by the Director of Nursing during interviews. Additionally, there was a documented discrepancy in the quantity of Hydromorphone tablets received, with conflicting documentation by two nurses regarding the number of tablets accepted by the facility. The facility did not follow its own policy for managing controlled substances when the discrepancy was identified. The nursing supervisor was not notified, a Controlled Drug Discrepancy Investigation Form was not completed, and no investigation into the discrepancy was initiated. The facility's policy requires that any discrepancies in controlled drug receipt or administration be reported and investigated immediately, but this process was not followed in this case.

An unhandled error has occurred. Reload 🗙